MRSA is an antibiotic-resistant staph infection that can be deadly for those in hospital care or with weakened immune systems. Staphylococcus aureus bacteria live in the nose without necessarily ...

Some MRSA infections could be tackled using widely-available antibiotics, suggests new research from an international collaboration led by scientists at the University of Cambridge and the Wellcome ...

MRSA (methicillin-resistant Staphylococcus aureus) is a well known superbug, a pathogenic microbe that can cause serious or fatal infections, which are resistant to treatment with standard antibiotics ...

Developing a MRSA infection during pregnancy is rare. MRSA is treatable but can lead to complications. If you have MRSA while pregnant, the risk to your baby is highest during delivery. Share on ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Former wrestler Jimmy Rave has revealed that an MRSA infection in both ...

October 24, 2011 (Orlando, Florida) — While the prevalence of methicillin-resistant Staphylococcus aureus (MRSA), particularly the community-acquired form, in ophthalmic infections continues to rise, ...

A new study has found the antimicrobial properties of certain stem cell proteins could offer a potential treatment to reduce infection in skin wounds. A new Cornell study has found the antimicrobial ...

Imagine falling seriously ill with an infection. Normally, we visit the doctor, are prescribed antibiotics, and after 7–10 days, we're back on our feet. But today, it is no longer guaranteed that the ...

YONKERS, N.Y., Oct. 26, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX) a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), ...

Imagine two people talking over a walkie-talkie set. Successful communication depends on them being tuned to the same frequency. If others try to communicate nearby, interference can occur, and ...

YONKERS, N.Y., Feb. 24, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), ...